Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
2019
Abstract Background In a single-group, phase 1b trial, avelumab plus axitinib resulted in objective responses in patients with advanced renal-cell carcinoma. This phase 3 trial involving previously...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
29
References
925
Citations
NaN
KQI